SCHEMBL23555751

SCHEMBL23555751

c1ccc2c(c1)sc1c3ccc(-c4ccc5c(ccc6cc(-c7ccc8c(c7)sc7c9ccccc9sc87)ccc65)c4)cc3sc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
ALDH1A1 P00352 2/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LIMK1 P53667 4/20 0.40
GPR3 P46089 1/20 0.40
ALOX5 P09917 1/20 0.40
HIF1A Q16665 1/20 0.38
CYP1B1 Q16678 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TNKS O95271 2/20 0.36
TNKS2 Q9H2K2 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPRT1 P00492 1/20 0.35
ERBB2 P04626 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23555707 1.00 MAPT (0.42) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23555973 0.98 LIMK1 (0.42) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23556042 0.95 MAPT (0.43) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23555946 0.93 CYP1B1 (0.47) MAPTALDH1A1HPGDLIMK1HIF1A
SCHEMBL23555971 0.93 LIMK1 (0.43) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23555748 0.91 MAPT (0.41) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23556043 0.91 MAPT (0.48) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23555747 0.90 MAPT (0.40) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23556038 0.89 LIMK1 (0.47) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23556037 0.89 LIMK1 (0.47) MAPTALDH1A1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes SONY CORPORATION (JP) 2023-09-26 US disclosed
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes SONY CORPORATION (JP) 2023-09-26 US disclosed
US-20210193935-A1 P ACTIVE MATERIALS FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES SONY CORPORATION (JP) 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes JUP, L1CAM, EPCAM MAPT 1030/4885ALDH1A1 2995/4885RAB9A 2248/4885
US-20210193935-A1 P ACTIVE MATERIALS FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES JUP, L1CAM, EPCAM MAPT 1030/4885ALDH1A1 2995/4885RAB9A 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.